VANCOUVER, B.C. — Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will report its fourth quarter and full year 2021 financial results after market… Read More
The audit, consulting and tax services company is expanding its business ConvergeHEALTH and launching two other businesses in the consumer and financial sectors. It’s investing in everything from new software… Read More
ZT-01 restored glucagon secretion, and reduced the frequency and severity of hypoglycemia in preclinical model of insulin-induced hypoglycemia TORONTO — Zucara Therapeutics Inc., a diabetes life sciences company developing the… Read More
Merck Has Completed Manufacturing of 10 Million Courses of Therapy and Remains on Track to Produce at Least 20 Million Courses in 2022 to Provide Widespread Access to Molnupiravir Globally… Read More
British Columbia is proving once again that it is a leading global hub for biotech innovation. Gandeeva Therapeutics, a Vancouver-based company led by UBC Faculty of Medicine professor Dr. Sriram… Read More
